Lucence Company

Lucence is a company that produces Liquid Biopsy Tests for cancer detection and treatment. These tests are ultrasensitive and non-invasive, requiring only a single draw of blood.

Founded Date: 42461
Total Funding: $29.2M
Investor Type: For Profit
Employee Number: 11-50
Funding Status: Early Stage Venture
Technology: diagnostics
Last Funding Type: Series A
Investors Number: 5
Last Funding Date: 2019-11-20
Industry: Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
Headquarters: Singapore
Estimated Revenue: $10M to $50M